These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21180666)

  • 1. Switching, combination, and augmentation strategies for major depressive disorder.
    Papakostas GI
    Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl 3):S9-14. PubMed ID: 21180666
    [No Abstract]   [Full Text] [Related]  

  • 2. Augmentation strategies in the treatment of major depressive disorder. Clinical considerations with atypical antipsychotic augmentation.
    Gitlin MJ
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):13-5. PubMed ID: 18389929
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic augmentation in treatment-resistant major depressive disorder.
    Delgado A; Ehert M
    Conn Med; 2011 Mar; 75(3):153-6. PubMed ID: 21500706
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.
    Thase ME
    CNS Spectr; 2009 Mar; 14(3 Suppl 4):7-10. PubMed ID: 19407714
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.
    Papakostas GI
    Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Likelihood to be helped or harmed can assist in clinical decision-making.
    Citrome L
    J Clin Psychiatry; 2011 Feb; 72(2):261-2; author reply 262. PubMed ID: 21382311
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 9. Combining antidepressant therapies from the initiation of treatment: a paradigm shift for major depression.
    Stahl SM
    J Clin Psychiatry; 2009 Nov; 70(11):1493-4. PubMed ID: 20031093
    [No Abstract]   [Full Text] [Related]  

  • 10. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.
    Hamoda HM; Osser DN
    Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can nonantidepressants help treat depression?
    Chilakamarri G; Weismantel D; Weismantel A
    J Fam Pract; 2009 Oct; 58(10):550-1. PubMed ID: 19874735
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternatives for "difficult to treat" MDD.
    Glazer WM
    Behav Healthc; 2010 Feb; 30(2):30-2. PubMed ID: 20333933
    [No Abstract]   [Full Text] [Related]  

  • 13. Switch or augment? Lessons from STAR*D.
    Nierenberg AA
    Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl 3):S4-8. PubMed ID: 21180665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of sertraline on blood clozapine].
    Darchy A; Fdhil H; Canceil O
    Encephale; 1998; 24(2):156-7. PubMed ID: 9622795
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs.
    Mohamed S; Leslie DL; Rosenheck RA
    J Clin Psychiatry; 2009 Jun; 70(6):906-12. PubMed ID: 19422760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation strategies in the treatment of major depressive disorder. Examining the evidence on augmentation with atypical antipsychotics.
    Papakostas GI
    CNS Spectr; 2007 Dec; 12(12 Suppl 22):10-2. PubMed ID: 18396509
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing treatment-resistant major depression.
    Nelson JC
    J Clin Psychiatry; 2003; 64 Suppl 1():5-12. PubMed ID: 12625799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy.
    Okamoto H; Shimizu E; Ozawa K; Hashimoto K; Iyo M
    Aust N Z J Psychiatry; 2005; 39(1-2):108. PubMed ID: 15660714
    [No Abstract]   [Full Text] [Related]  

  • 19. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
    Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.